XM does not provide services to residents of the United States of America.

Nasdaq outshines Wall St peers on tech boost, earnings glee



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Nasdaq outshines Wall St peers on tech boost, earnings glee</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Visa rises after Q2 results beat

Meta, Snap up after Senate passes TikTok ban bill

Indexes: Dow down 0.09%, S&P up 0.29%, Nasdaq up 0.81%

Updated at 9:39 a.m. ET/1339 GMT

By Shristi Achar A and Shashwat Chauhan

April 24 (Reuters) - The Nasdaq outpaced Wall Street peers onWednesday, with Tesla leading gains among megacap stocks after its quarterly results, while upbeat earnings reports across other sectors also offered support.

Tesla TSLA.O led gains acrossmegacap stocks with a 9.7% jump after the electric-vehicle maker eased some worries about growth with a prediction that sales would rise this year and said it would roll out more affordable models in early 2025.

Some other growth stocks also advanced, with Microsoft MSFT.O and Nvidia NVDA.O up 0.8% and 1.6%, respectively.

The earnings season was in full swing with drugmaker Biogen BIIB.O adding 3.7% on beating first-quarter profit expectations.

Boston Scientific BSX.N rose 6.1% after the medical device maker raised its annual profit forecast.

Hasbro HAS.O gained 13.9% after the toymaker reported a smaller-than-expected drop in first-quarter sales and handily beat profit estimates.

Wabtec WAB.N advanced 10.8% after the heavy industrial parts maker raised its full-year profit forecast.

Meanwhile, social media firms Meta Platforms META.O and Snap SNAP.N gained 1.8% and 0.6%, respectively, after the U.S. Senate passed a bill late on Tuesday that would ban TikTok in the United States if its owner, the Chinese tech firm ByteDance, failed to divest the popular short video app.

Meta, Microsoft and Alphabet GOOGL.O are scheduled to report their quarterly results later this week.

"Last week was really rough for the Nasdaq, it was almost indiscriminate selling of all growth stocks," said Russell Hackmann, president of Hackmann Wealth Partners.

"So certainly you're just kind of seeing some bounce."

U.S. equities have recouped some losses following last week's slump when investors turned risk-off amid tensions in the Middle East and more data prompting a tuning to their rate-cut expectations from the Federal Reserve.

On the data front, new orders for key U.S.-manufactured capital goods rose moderately in March and data for the prior month was revised lower, suggesting business spending on equipment was likely sluggish in the first quarter.

Focus will now shift to themuch anticipated Personal Consumption Expenditures (PCE) index reading for March, the Fed's preferred inflation gauge, due on Friday.

At 9:39 a.m. ET, the Dow Jones Industrial Average .DJI was down 33.34 points, or 0.09%, at 38,470.35, the S&P 500 .SPX was up 14.60 points, or 0.29%, at 5,085.15, and the Nasdaq Composite .IXIC was up 127.90 points, or 0.81%, at 15,824.54.

Eight of the 11 major S&P 500 sectors were trading lower, with utilities .SPRLCU the worst hit. Consumer discretionary .SPLRCD was amongst top gainers.

Visa V.N added 2.4% after the payments processing giant's second-quarter results sailed past Wall Street estimates.

Texas Instruments TXN.O climbed 6.2% after the chipmaker forecast second-quarter revenue above analysts' estimates.

The Philadelphia Semiconductor Index .SOX rose2.9% as most chip stocks rallied.

Solar inverter maker Enphase Energy ENPH.O lost 3.3% after projecting second-quarter revenue below analysts' estimates.

Declining issues outnumbered advancers for a 1.45-to-1 ratio on the NYSE. Advancing issues outnumbered decliners by a 1.04-to-1 ratio on the Nasdaq.

The S&P index recorded seven new 52-week highs and two new lows, while the Nasdaq recorded 22 new highs and 27 new lows.



Reporting by Shristi Achar A and Shashwat Chauhan in Bengaluru; Editing by Pooja Desai and Maju Samuel

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.